ANDA 85916, held by Sandoz. Diethylpropion Hydrochloride.
As of Nov 16, 2026, ANDA 85916 (Diethylpropion Hydrochloride), held by Sandoz, was first approved by FDA on Sep 16, 1994, with 5 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 16, 1994 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Diethylpropion Hydrochloride25MG ยท tablet;oral | Diethylpropion Hydrochloride | Discontinued |
| Sep 16, 1994 | Original application | Approved | None posted |
| Jun 26, 1989 | Supplement 18Bioequivalence | Approved | None posted |
| Mar 2, 1983 | Supplement 9Manufacturing | Approved | None posted |
| Mar 2, 1983 | Supplement 8Manufacturing | Approved | None posted |
| Mar 2, 1983 | Supplement 7Manufacturing | Approved | None posted |
| Oct 20, 1982 | Supplement 10Manufacturing | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters